AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
1-Year Return
18.84%
This Quarter Return
+2.09%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$297M
AUM Growth
+$56.9M
(+24%)
Cap. Flow
+$52.6M
Cap. Flow
% of AUM
17.72%
Top 10 Holdings %
Top 10 Hldgs %
80.3%
Holding
232
New
27
Increased
80
Reduced
67
Closed
26
Top Buys
| 1 |
iShares MBS ETF
MBB
|
$24.9M |
| 2 |
Invitation Homes
INVH
|
$7.36M |
| 3 |
American Homes 4 Rent
AMH
|
$3.63M |
| 4 |
Luminar Technologies
LAZR
|
$1.22M |
| 5 |
Galapagos
GLPG
|
$1.13M |
Top Sells
| 1 |
Globus Medical
GMED
|
$978K |
| 2 |
Omnicell
OMCL
|
$650K |
| 3 |
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
|
$568K |
| 4 |
RAVN
Raven Industries Inc
RAVN
|
$383K |
| 5 |
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
|
$247K |
Sector Composition
| 1 | Real Estate | 18.29% |
| 2 | Healthcare | 13.15% |
| 3 | Technology | 2% |
| 4 | Industrials | 1.37% |
| 5 | Consumer Discretionary | 1.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vertex Pharmaceuticals
VRTX
$102B
| $860K | 0.29% |
4,000
+2,950
| +281% | +$634K |
|
|
NNDM
27
Nano Dimension
NNDM
$296M
| $859K | 0.29% |
100,000
-25,000
| -20% | -$215K |
|
|
VIRX
28
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $855K | 0.29% |
+92,402
| New | +$855K |
|
29
Microbot Medical
MBOT
$163M
| $851K | 0.29% |
100,000
| – | – |
|
30
Cogent Biosciences
COGT
$1.81B
| $790K | 0.27% |
90,000
+70,300
| +357% | +$617K |
|
31
AgEagle Aerial Systems
UAVS
$60.2M
| $783K | 0.26% |
+125
| New | +$783K |
|
32
Gilead Sciences
GILD
$140B
| $763K | 0.26% |
11,800
| – | – |
|
33
Sarepta Therapeutics
SRPT
$1.93B
| $708K | 0.24% |
9,500
+8,775
| +1,210% | +$654K |
|
34
Kohl's
KSS
$1.84B
| $674K | 0.23% |
11,299
-381
| -3% | -$22.7K |
|
35
Y-mAbs Therapeutics
YMAB
$389M
| $665K | 0.22% |
22,000
+19,000
| +633% | +$574K |
|
|
CYBE
36
DELISTED
Cyberoptics Corp
CYBE
| $649K | 0.22% |
25,000
| – | – |
|
37
Applied Therapeutics
APLT
$67M
| $619K | 0.21% |
+33,000
| New | +$619K |
|
38
BioMarin Pharmaceuticals
BMRN
$10.9B
| $604K | 0.2% |
8,000
+500
| +7% | +$37.8K |
|
39
Legend Biotech
LEGN
$6.46B
| $580K | 0.2% |
+20,000
| New | +$580K |
|
40
Axsome Therapeutics
AXSM
$6.21B
| $566K | 0.19% |
+10,000
| New | +$566K |
|
41
Karyopharm Therapeutics
KPTI
$58.4M
| $547K | 0.18% |
3,467
+2,334
| +206% | +$368K |
|
|
ZGNX
42
DELISTED
Zogenix, Inc.
ZGNX
| $527K | 0.18% |
27,000
+11,500
| +74% | +$224K |
|
43
Celldex Therapeutics
CLDX
$1.51B
| $515K | 0.17% |
25,000
+21,500
| +614% | +$443K |
|
44
Incyte
INCY
$16.7B
| $508K | 0.17% |
6,250
+3,750
| +150% | +$305K |
|
45
Invesco
IVZ
$9.79B
| $503K | 0.17% |
19,943
-531
| -3% | -$13.4K |
|
46
MGM Resorts International
MGM
$10.1B
| $497K | 0.17% |
13,088
-441
| -3% | -$16.7K |
|
47
Mersana Therapeutics
MRSN
$35.5M
| $493K | 0.17% |
1,220
+1,036
| +563% | +$419K |
|
|
ASXC
48
DELISTED
Asensus Surgical, Inc.
ASXC
| $488K | 0.16% |
+150,000
| New | +$488K |
|
49
Aurinia Pharmaceuticals
AUPH
$1.65B
| $454K | 0.15% |
35,000
+15,000
| +75% | +$195K |
|
50
iShares Mortgage Real Estate ETF
REM
$612M
| $446K | 0.15% |
12,644
-10
| -0.1% | -$353 |
|